N/A
N=301
Vestibular Infants Screening-Flanders
Vestibular Disorder · Hearing Impaired Children
Bottom Line
View on ClinicalTrials.gov: NCT05061069 ↗Enrolled (actual)
301
Serious AEs
—
Results posted
Feb 2025
Primary outcome: Primary: Number of Hearing-impaired Infants in Flanders With Abnormal Vestibular Screening Results. — 35 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- cervical vestibular evoked myogenic potentials (cVEMP) (Diagnostic_test)
- Age
- Pediatric · 0+ yrs
- Sex
- All
- Sponsor
- University Hospital, Ghent
- Primary completion
- Jul 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Hearing-impaired Infants in Flanders With Abnormal Vestibular Screening Results. |
35 | — |
Summary
Hearing-impaired children are at risk for a vestibular impairment, as the auditory and vestibular end organs are closely related. Although this can compromise a child's development on many levels, vestibular testing is not routinely performed in this vulnerable group. This project aims to give each congenitally hearing-impaired child in Flanders (Belgium) access to a basic vestibular screening at a young age and set an example for other regions worldwide.
Eligibility Criteria
Inclusion Criteria
- Flemish children with permanent congenital or delayed-onset hearing loss, which occurred before the age of 9 months, are included.
Exclusion Criteria
- Children with temporary hearing loss (e.g. due to otitis media) are excluded.
Data sourced from ClinicalTrials.gov (NCT05061069). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.